Atlas Trials

Disseminated Tumor Cell

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Disseminated Tumor Cell

RecordFirmDate
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER) (NCT04333706)University of Southern California2020-09-26

Track Disseminated Tumor Cell automatically

Every clearance here is in the API, with alerts when new ones post.